A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)
Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
A Study to Evaluate the Pharmacokinetics and Safety of Golcadomide in Participants With Severe Renal Impairment and End-Stage Renal Disease Compared With Participants With Normal Renal Function
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
Zanzalintinib Alone or in Combination With Pembrolizumab and Berahyaluronidase Alfa in Participants With Colorectal Cancer With Molecular Residual Disease
Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma
Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors
Cancer clinical trials in Melbourne, FL
Cancer research makes up a large share of the studies on the Space Coast, and many local cancer studies run through Cancer Care Centers of Brevard. Studies often cover lung cancer and breast cancer, along with digestive system cancers; see our oncology clinical trials page and our guides to lung cancer treatment and breast cancer treatment.
Other clinical trials on the Space Coast
Studies in Melbourne, Palm Bay, and Viera also cover fatty liver disease, Alzheimer's disease and memory loss, depression and other mental health conditions, kidney disease, and weight loss.
Do clinical trials in Melbourne pay?
Some studies offer compensation for time and travel, and study related care is typically provided at no cost to participants. Compensation varies by trial and is always described during the informed consent process before you agree to anything. The institutional review board that oversees each study must approve any payment before the study begins, and FDA guidance treats payment as a way to recognize your time, not as a benefit of taking part. If you receive payment, it is usually spread across the visits you complete.
Our guide explains how much clinical trials pay and how payment is decided.
Can I join a cancer clinical trial while getting standard treatment?
Sometimes. Some cancer studies add an investigational treatment to standard care, others compare a new treatment with the standard one, and some require that you have not yet started treatment. Talk to your oncologist before you apply; our guide to standard treatment versus clinical trials can help you weigh the options.
How to join a clinical trial in Melbourne
- Identify your trial. Use the filters on this page to narrow the list by condition or phase, or search a diagnosis such as breast cancer or fatty liver disease.
- Check the location. Each study lists the sites where it recruits, so confirm it has a site in Melbourne, Palm Bay, Viera, or elsewhere in Brevard County.
- Explore study details. Read the eligibility criteria and, where listed, the number of visits and how long the study lasts before applying.
- Complete the health profile. Click "See if you qualify" to begin the 5-step application. Have ready your diagnosis and when it was made, the medicines you take, and any recent test results.
- Submit the application. A clinical trial coordinator reviews it and contacts you to discuss next steps. Nothing is decided until informed consent, and participation is voluntary at every step.
Our guide to finding clinical trials near you covers each step in more detail.
Clinical trials near Melbourne: Orlando, Port St. Lucie, and Daytona Beach
Studies in Melbourne, Palm Bay, Viera, and other Brevard County towns appear on this page. For more options, our Orlando page covers the larger research programs about an hour northwest, Port St. Lucie is about an hour south, and Daytona Beach is about 70 miles north; studies across the state are on our Florida clinical trials page.